logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan.

    Article, Communication - En anglais

    The spector of Glycopeptide Resistance : Current Trends and Future Considerations. Satellite symposium. Toronto, ON, CAN, 1997/09/27.

    Within the past year, infections caused by methicillin-resistant Staphylococcus aureus (MRSA) strains with reduced susceptibility to vancomycin (MIC=8 mug/mL) have been reported in both Japan and the United States.

    The emergence of these strains poses a potentially serious threat to public health.

    After 2 such strains (Mu3 and Mu50) were identified at Juntendo Hospital in 1996, a screening program to identify MRSA strains with reduced susceptibility to vancomycin was initiated.

    Of 970 MRSA strains tested at 195 nonuniversity hospitals throughout Japan, 13 (1.3%) were found to have subpopulations with reduced vancomycin susceptibility (heterogeneous vancomycin resistance).

    Among 129 MRSA strains identified at 7 university hospitals, 12 (9.3%) demonstrated heterogeneity for vancomycin resistance ; 1 of these strains had a vancomycin MIC of 7 mug/mL.

    Although resistance in these strains is not the result of the transfer of enterococcal vancomycin resistance genes (vanA or vanB), the clonal dissemination of MRSA strains with vancomycin-resistant subpopulations is obviously undesirable.

    Intensified testing of MRSA strains for resistance to vancomycin and appropriate measures for the prevention of the spread of such strains are recommended.

    Mots-clés Pascal : Bactériose, Infection, Staphylococcus aureus, Micrococcaceae, Micrococcales, Bactérie, Acquisition, Résistance traitement, Chimiothérapie, Antibactérien, Vancomycine, Glycopeptide, Epidémiologie, Homme, Japon, Asie, Polypeptide

    Mots-clés Pascal anglais : Bacteriosis, Infection, Staphylococcus aureus, Micrococcaceae, Micrococcales, Bacteria, Acquisition, Negative therapeutic reaction, Chemotherapy, Antibacterial agent, Vancomycin, Glycopeptide, Epidemiology, Human, Japan, Asia, Polypeptide

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0443675

    Code Inist : 002B02S02. Création : 25/01/1999.